Ulerythema ophryogenes and keratosis follicularis spinulosa decalvans are rare folliculocentric keratotic disorders, from the group of follicular genokeratoses, characterized by keratosis pilaris atrophicans: follicular keratotic papules, sometimes with surrounding erythema, which eventually result in fi brosis, atrophy, progressive scarring and permanent hair loss. Ulerythema ophryogenes begins at birth or soon thereafter; it involves the lateral eyebrows, spreads medially and eventually affects the entire eyebrows, cheeks, and less frequently, forehead and asjecebt scalp. Involvement of the scalp has apparently not been reported in cases in which the eyebrows were predominantly involved. In addition to sporadic cases, ulerythema ophryogenes has been reported among relatives. Keratosis follicularis spinulosa decalvans is also a genetically heterogeneous syndrome which begins in infancy or childhood by involving hair bearing skin, especially the scalp; rarely it is confi ned to the face involving only eyebrows and eyelashes, but affects predominantly the scalp, leading to severe progressive cicatricial alopecia. Both conditions tend to progress until puberty. The authors present a case of an otherwise healthy 19-year-old male patient, with absence of lateral eyebrows since childhood, which spread symmetrically and medially, until puberty affecting the entire eyebrows, whereas the eyelashes were completely spared. On examination, skin fi ndings on the face, trunk and extremities pointed to ulerythema ophryogenes: apart from hair loss, the lateral eyebrows were highly erythematous; a great number of disseminated follicular, slightly keratotic papules (keratosis pilaris) pin-or match-head sized, were seen on the trunk, extensor surface of the arms and legs, as well as the buttock, and on palpation the skin felt like a "nutmeg grater". However, follicle-based erythematous papules (focal patchy alopecia) were found not only along the eyebrows but also partly in the parietal capillitium forming focal patchy alopecia, which is a fi nding characteristic for keratosis follicularis spinulosa decalvans; the histopathological analysis of the biopsy specimens taken from the parietal capillitium has confi rmed the clinical diagnosis. Cytogenetic analysis showed no karyotypic abnormalities. Family history showed that the patient's mother and maternal grandfather also suffered from hair loss especially of the lateral eyebrows. This paper presents an overlap between two rare follicular genokeratoses in a young male with a positive family history, who presented with ulerythema ophryogenes involving not only the eyebrows, but also the scalp, in the form of parietal, focal cicatricial patchy alopecia.
a great number of disseminated follicular, slightly keratotic papules, pin-or match-head sized, were seen on the capillitium, eyebrows, cheeks, trunk, extensor surface of the arms and legs, as well as the buttocks, and on palpation the skin felt like a "nutmeg grater" (Figures 1, 2) ; follicle-based erythematous papules were found not only along the eyebrows and cheeks, but also partly in the parietal capillitium, with atrophy and alopecia (Figures 3, 4, 5) .
Histopathological analysis of the biopsy specimens taken from an area of hair loss on the parietal capillitium, which included follicule-based erythematous papules, revealed dilated hair follicles fi lled with keratin, infundibular atrophy, perifollicular lymphocytic infi ltrates and fi nally, fi brosis ( Figure 6 and 7).
Karyotype: in 11 examined metaphases, 46 XY karyotype was found, without fragile chromosomal sites.
at birth or soon thereafter; it involves the lateral eyebrows, spreads medially and eventually aff ects the entire eyebrows, cheeks, and, less frequently extends to the adjacent scalp. Involvement of the scalp has apparently not been reported in cases in which the eyebrows were predominantly involved (4) . In addition to sporadic cases, UO has been reported among relatives; it is assumed that in these cases it is transmitted through autosomal dominant inheritance pattern with variable penetrance (1, 2) .
Keratosis follicularis spinulosa decalvans (KFSD) is also a genetically heterogeneous syndrome characterized also with KPA, but contrary to UO, which particularly and initially, to a greater or lesser extent, aff ects the eyebrow areas, KFSD usually begins in late infancy or childhood by aff ecting hair bearing skin, especially the scalp; it is rarely confi ned to the face involving only eyebrows and eyelashes, but aff ects predominantly the scalp, leading to severe progressive cicatricial alopecia (2, 3, 5) ; an X-linked inheritance has been proposed with random lyonization, because men are more severely aff ected than women (2) . In both conditions progression usually stops after puberty (2, 3) , and they may show overlapping features and inconclusive, non-diagnostic histopathology (2, 4) .
Th e authors present an overlap between two rare follicular genokeratoses in a young male with a positive family history, who presented with UO involving not only the eyebrows, but also the scalp, in the form of parietal, focal cicatricial patchy alopecia.
Case report
A 19-year-old, otherwise healthy male student, was referred for dermatologic examination due to numerous slightly itchy follicular hyperkeratotic papules surrounded by an erythematous halo, that were confi ned to the infl amed skin of the parietal scalp and followed by hair loss. Th e patient had a history of lateral eyebrow loss since infancy, and subsequent development of follicle-based hyperkeratotic papules, 1 -2 mm in diameter, on the trunk and dorsal aspects of the limbs. Th e family history showed that the patient's mother and maternal grandfather also suff ered from hair loss especially of the ateral eyebrows.
On examination, fi ndings indicated UO: apart from lateral eyebrow loss, the eyelashes were completely spared; the skin of the face was highly erythematous; Figure 1 . Disseminated follicular, slightly keratotic papules, pin-or match-head sized, on the extensor surface of the arms Figure 2 . Disseminated follicular, slightly keratotic papules, pin-or match-head sized, on the extensor surface of the arms (KP) is often present on the trunk and extremities; sometimes it may be associated with conditions such as ichthyosis vulgaris and xerosis (1, 2) . Although in cases where signs of the syndrome are incomplete or not clearly expressed, KPA is not easily diff erentiated from KP, one should take into account that KP (either isolated or associated with atopic dermatitis, vulgar ichthyosis or other ectodermal disorders), causes no follicular destruction, atrophy, scarring or changes on the face and scalp characterized by KPA associated with follicular syndrome with infl ammation and atrophy. While hyperkeratosis in KP is limited to the openings of hair follicles, in KPA it involves the infundibulum and isthmus and with hypergranulosis represent the fi rst visible histopathological features. Follicular hyperkeratosis cannot be considered the only cause of acute infl ammatory changes in the hair follicles (accompanied by simultaneous accumulation of neutrophils and development of intracellular edema in the interfollicular epidermis and papillary dermis), perifollicular arrangement of collagen fi bers, accumulation of mucin and mononuclear cells in the Dermatoglyphic fi ndings: normal, unremarkable. Diagnosis of UO/KPSD overlap was based on history, clinical presentation, course of the disease, and histopathological fi ndings of the biopsy specimens taken from an area of hair loss on the capillitium: changes began in early infancy, predominantly aff ected the lateral third of the eyebrows, eyelashes were spared, KP was present on the trunk and dorsal aspects of the limbs, whereas around puberty the patient presented with patchy changes on the parietal capillitium, with follicular keratotic-erythematous papules and atrophy, in the form of parietal, focal cicatricial patchy alopecia.
Th erapy included oral doxycycline, 100 mg per day, for initial control of the infl ammatory component, combined with a topical steroid, and 2% salicylic acid in 20% urea cream.
Discussion
Keratosis pilaris atrophicans (KPA) is clinically characterized by keratotic follicular papules followed by atrophy, scarring and permanent hair loss. If the pathological process aff ects hair follicles on the scalp, it results in diff use scarring alopecia. Keratosis pilaris Figure 3 . Erythema of the face same process (ie. KPA), and that by distribution of changes, severity of infl ammation, and the degree of atrophy, they can be classifi ed into one of three existing groups: 1) keratosis pilaris atrophicans faciei (KPAF); 2) atrophoderma vermiculatum (AV); and 3) keratosis follicularis spinulosa decalvans (KFSD) (7) . Moreover, AV (synonyms: atrophoderma reticulatum; folliculitis erythematosa reticulata; English -honeycomb atrophy; French -Acne vermoulant) is characterized by symmetrical, preauricular small follicular erythematous papules which are quickly followed by atrophic scars and small, pit-like, atrophic areas, irregular in shape and bounded by narrow ridges, giving the cheeks a worm-eaten appearance and may represent an end stage of the preceding two diseases. Another group of authors argues that the KPAF, KFSD, AV and folliculitis spinulosa decalvans (FAD), described by Van Ouch in 1992 (8) , are four clearly distinct clinical entities characterized by the presence of keratosis pilaris atrophicans (2, 9) . Th us, atrophoderma vermiculatum, as a clearly distinct clinical and pathomorphological entity, may be associated with various syndromes and multiple anomalies, reviewed by Schaller and associates (10) . 
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fi nal phase of the follicular destruction; it is supposed that unknown etiological factors lead to release of cytokines from follicular keratinocytes, which then induce hyperkeratosis and infl ammatory changes (2, 6) .
Numerous syndromes characterized by KPA have been described. As these syndromes have overlapping features and non-diagnostic histology, as in our case, some authors believe that they represent diff erent stages in the development of the keratosis rubra pilaris faciei atrophicans, folliculitis rubra) is derived from the Greek words: ule which means a scar, and ophrys which means eyebrow (3). UO was fi rst described by Erasmus Wilson in 1878 (13) . As mentioned previously, scalp involvement with scaring alopecia has not been reported in UO, particularly not in cases where eyebrows were predominantly aff ected, like in our case. However, there are reports on diagnosed UO cases with alopecia of the scalp; in order to improve diagnostic accuracy, such cases should be reclassifi ed into one of aforementioned conditions (in which alopecia may occur) (4) . KFSD initially appears morphologically in relation to KPAF, but with a more extensive pattern of involvement (5) . Th e scaring alopecia in KFSD may be localized or extensive, involving eyebrows and eyelashes (madarosis) as well as the scalp; however, alopecia is typically patchy, such as in our patient, since the process usually does not aff ect the entire scalp (2). Other features include facial erythema, which was also present in our patient; photophobia, ophthalmitis, and palmar-plantar keratoderma, may also be present, and although characteristic, these features are not pathognomonic for the disease (2, 3). KFSD was originally described by Lameris in 1905, under the name ichthyosis follicularis (IF) (14) ; the term keratosis follicularis spinulosa decalvans was created by Siemens, in 1926, when he described some individuals from a Bavarian family with keratosis follicularis spinulosa decalvans (15) . Most aff ected families with KFSD show X-linked inheritance: it was found that the gene responsible for KFSD is located on chromosome Xp22.13 -p22.2, mapped between AFM291wf5 and AFM316yf5 (2). Aten and associates investigated patients with KFSD and confi rmed mutation in the MBTPS2 gene; it has been established that this mutation decreases the activity of the enzyme involved in the metabolism of cholesterol and the barrier function of the epidermis (16) .
Th e histopathological fi ndings of KFSD depend on the stage of the disease and site of biopsy. Skin biopsies taken from the thorax and extremities show fi liform follicular hyperkeratosis, while those taken from the scalp and eyebrows go through four stages: 1) acute or infl ammatory stage, where dilated hair follicles are fi lled with keratin and dystrophic root; follicular epithelium in the isthmus and infundibulum Similarly, KPAF is considered a marker of certain syndromes such as Noonan syndrome (11) and Zouboulis syndrome (monosomy 18p syndrome) (12) . Th e later represents a trias of KP, KPAF and 18p monosomy, suggesting that genes responsible for follicular keratinization could be located on the short arm of chromosome 18 (12) .
Th e term ulerythema ophryogenes (UO), (synonyms: keratosis pilaris atrophicans faciei, Figure 6 . Th e epidermis is moderately hyperkeratotic, with elongation of rete ridges; some hair follicles are dilated, some show fi brous scarring, surrounded with chronic mononuclear cell infi ltrates Figure 7 . Th e follicular epithelium has been replaced by fi brous connective tissue; sebaceous glands are missing, and sweat glands are spared so it can be assumed that KAP syndrome and KFSD represent overlap within the spectrum of phenotypes of the same genetic disorder, but alopecia in KAP syndrome is always nonscarring, unlike in KFSD (17) . In most cases the process resolves by puberty, but the consequences are permanent. Th e therapy is symptomatic, and there is no specifi c eff ective treatment: retinoids (isotretinoin, acitretin) should be used only during the active phase of the disease, which means in the early childhood. Hair loss is permanent, and treatment in the chronic phase, ie. after puberty, which is by far the most common case, only alleviates the existing hyperkeratotic changes. Antibiotic treatment should be carried out only in periods of acute exacerbation, which is manifested by erythema and scarce pustules on the scalp. Biopsy specimens may show Staphylococcus aureus, and the treatment should be carried out according to the antibiogram. Topical steroids and keratolytics may partially improve the symptoms, but after cessation of therapy, the benefi ts are lost. Tretinoin (0.1% cream once daily), may induce or aggravate the existing erythema, that can be avoided by concomitant use of corticosteroid creams (once or twice a day), or topicalretinoic acid 0.025% on alternate days for the scalp at night. Hair removal with a long-pulse Q-switched ruby laser has been found to be useful in progressive orrecalcitrant KFSD. Atrophic lesions may be treated with dermabrasion and/or application of collagen implants, now considered to be the most successful treatment modality. Ablative laser skin resurfacing is done using ultrapulse CO2 or YAG (yttrium aluminum garnet) laser (2) . A signifi cant erythema reduction is achieved by using 585 nm pulsed dye laser (18) .
Conclusion
Th e authors present an overlap between two rare follicular genokeratoses in a young male with a positive family history, who presented with ulerythema ophryogenes involving not only the eyebrows, but also the scalp, in the form of parietal, focal cicatricial patchy alopecia.
Abbreviations
UO -ulerythema ophryogenes KFSD -keratosis follicularis spinulosa decalvans KPA -keratosis pilaris atrophicans show acanthosis, hypergranulosis, hyperkeratosis, in some cases concomitant accumulation of neutrophils and intracellular edema in the hyperkeratotic interfollicular epidermis and papillary dermis; 2) stage with perifollicular accumulation of mononuclear cells, scarce infi ltrates containing predominantly lymphocytes and plasma cells, followed by accumulation of perifollicular mucin and thickened collagen fi bers, extending parallel with the follicular wall; 3) stage of hair follicle destruction with more or less pronounced granulomatous infl ammatory response and increased accumulation of plasma and giant cells ("around the foreign body") directed towards so-called "bare" hair in the dermis and the remaining parts of disintegrated follicles; 4) the fi nal stage which cannot be distinguished from pseudopelade; hair follicles are replaced by fi brous streamers (stelae) (2) . Th ese stages were compatible with the fi ndings obtained from the biopsy specimens taken from the parietal scalp with alopecia in our patient.
Apart from histopathology, clinical history and course of the disease, diff erential diagnosis of certain conditions was helpful in establishing the fi nal diagnosis. Th e later included the following: 1. lolliculitis spinulosa decalvans is characterized by persisting infl ammation, exacerbation with pustular elements at puberty, when spontaneous improvement occurs in most patients with KFSD; 2. lichen planopilaris is characterized by atrophic scarring on the scalp, dominated by complete absence of follicular openings; adjacent hair follicles at the periphery of lesions, as well as residual hair follicles within the lesions are surrounded by erythematous perifollicular macula and scales; the edge of the area aff ected by alopeciashows acuminate keratotic plugs; 3. lichen spinulosus has a predilection for acral areas unlike keratosis pilaris. Th e horny spine that is characteristic of lichen spinulosus can be removed, leaving behind a tiny funnel-like orifi ce in the papule, whereas an entire individual lesion can be removed with the plug in keratosis pilaris; 4. Ichthyosis follicularis is present at birth, and is characterized by nonscarring alopecia; histopathologically, unlike KFSD, it presents without fi brosis; 5. Keratosis pilaris atrophicans (KPA) syndrome (keratosis pilaris, alopecia, photophobia or IF, alopecia and photophobia) is also due to mutations on MBTPS2 gene on chromosome Xp21.2 -p22.2, 
Ulerythema ophryogenes i keratosis follicularis spinulosa decalvans − prikaz slučaja

Sažetak
Ulerythema ophryogenes (UO) i keratosis follicularis spinulosa decalvans (KFSD) predstavljaju retke folikulocentrične keratotične poremećaje, koji pripadaju grupi folikularnih genokeratoza, u kojima dominira keratosis pilaris atrophicans (KPA): folikularno smeštene keratotične papule okružene manje ili više izraženim eritemom koje vremenom zamenjuje fi broza, atrofi ja, progresivno ožiljavanje i trajni gubitak dlake. Proces kod ulerythema ophryogenes započinje u prvim mesecima života i zahvata lateralne strane obrva, širi se medijalno, može zahvatiti obrve u celini i znatno ređe proširiti se na čelo i susedni deo kapilicijuma. Zahvatanje kapilicijuma nije karakteristično za ulerythema ophryogenes, naročito ne za slučajeve u kojima kliničkom slikom dominiraju promene na obrvama. Pored sporadičnih slučajeva, opisana je i pojava ulerythema ophryogenes među srodnicima, pretpostavlja se da se u ovim slučajevima bolest prenosi autozomno dominantno sa varijabilnom penetracijom. Keratosis follicularis spinulosa decalvans takođe je heterogeni genetski sindrom za koji je karakteristična keratosis pilaris atrophicans, ali za razliku od ulerythema ophryogenes koji od samog početka zahvata manje ili više obrve, keratosis follicularis spinulosa decalvans obično započinje kasnije, u ranom detinjstvu i karakteristično zahvata kapilicijum, dovodeći u težim oblicima do progresivne ožiljne alopecije. Pretpostavlja se da se nasleđuje vezano za X-hromozom sa randominiziranom lajonizacijom, s obzirom da se bolest ispoljava sa znatno težim znacima kod osoba muškog pola u odnosu na žene. Kod ulerythema ophryogenes i keratosis follicularis spinulosa decalvans evolucija bolesti se u najvećem broju slučajeva zaustavlja u vreme puberteta, klinički znaci se međusobno mogu preklapati i biti istovremeno prisutni kod jednog istog pacijenta, a rezultati patohistološke analize ostati bez diferencijalno-dijagnostičkog značaja. Autori prikazuju overlap dve retke folikularne genokeratoze. Prikaz slučaja. Devetnaestogodišnji mladić, inače dobrog zdravstvenog stanja, upućen je na pregled dermatologu zbog pojave brojnih folikularnih hiperkeratotičnih papula okruženih eritematoznim haloom u parijetalnom delu kosmatog dela glave. Promene su bile praćene blagim osećajem svraba, skoncentrisane na jednom relativno jasno ograničenom ovalnom polju na kome je dlaka nedostajala a koža pokazivala znake infl amacije. Pacijent je dao podatak da su mu spoljašnji delovi obrva nedostajali od najrananijih meseci života, a da su mu se kasnije na trupu i ekstremitetima počeli javljati čvrsti, orožali čvorići veličine čiodine glavice 1-2 mm u prečniku. Analizom pedigrea se došlo do podatka da su spoljašnji delovi obrva nedostajali kod pacijentove majke i njenog oca. Prilikom objektivnog pregleda, nalaz je ukazivao na ulerythema ophryogenes: pored nedostatka dlaka, u lateralnim polovinama, obrva trepavice su bile potpuno pošteđene; koža je bila izrazito eritematozna; na kapilicijumu, obrvama, obrazima, na trupu i pretežno na ekstenzornim stranama ruku i nogu kao i na gluteusima, bio je prisutan veći broj diseminovanih folikularno smeštenih i lako keratotičnih papula veličine glavice čiode do šibice, koje su na palpaciju odavale utisak "trenice" (slike 1 i 2); duž obrva, obraza i na parijetalnom kapilicijumu nalazile su se folikularne eritematozne papule smeštene na eritematoznoj koži sa atrofi jom i alopecijom (slike 3−5). Patohistološka analiza isečka uzetog sa alopecijskog polja na parijetalnom kapilicijumu koji je obuhvatio i folikularno smeštene eritematozne papule, pokazala je proširene otvore dlačnih folikula ispunjene keratinom, atrofi ju infundibularnog dela folikuluma i perifolikularni limfocitni infi ltrat (slike 6 i 7). Dijagnoza ulerythema ophryogenes/follicularis spinulosa decalvans overlap je postavljena na osnovu anamneze kliničke slike, toka oboljenja i patohistološkog nalaza u isečku kože uzete sa regije koju je zahvatila alopecija u parijetalnom kapilicijumu: promene započele u prvim mesecima života, dominantno zahvatile lateralne trećine obrva, trepavice ostale očuvane; po trupu prisutna KP; u vreme puberteta pojavila se jasno ograničena solitarna promena na kapilicijumu sa folikularnim keratotično-eritematoznim papulama, atrofi jom, u formi parijetalne, fokalne ožiljne alopecije. Inicijalno je u terapiju uveden doksiciklin u dozi od 100 mg dnevno sa ciljem kontrole infl amacije, u kombinaciji sa topijskim kortikosteroidnim preparatom, 2% salicilnom kiselinom i kremom sa 20% uree. Diskusija. Keratosis pilaris atrophicans klinički se manifestuje folikularno smeštenim keratotičnim papulama koje postepeno zamenjuju znaci atrofi je, ožiljavanje i trajni gubitak dlake. Ukoliko su patološkim procesom zahvaćeni dlačni folikuli u kapilicijumu, nastaje difuzna ožiljna alopecija. Keratosis pilaris često je prisutna na trupu i ekstremitetima; Iako se u slučajevima u kojima su znaci sindroma nepotpuni ili nedovoljno jasno izraženi keratosis pilaris atrophicans teško razlikuje od keratosis pilaris, treba znati da keratosis pilaris (bilo izolovana ili udružena sa atopijskim dermatitisom, vulgarnom ihtiozom ili drugim ektodermnim poremećajima) ne izaziva destrukciju folikula, atrofi ju, ožiljavanje, niti promene na licu i poglavini koje karakterišu keratosis pilaris atrophicans u sastavu folikularnih sindroma sa infl amacijom i atrofi jom. Hiperkeratoza kod keratosis pilaris ograničena je na otvore dlačnih folikula, dok u keratosis pilaris atrophicans ona zahvata infundibulum i istmus i, uz hipergranulozu, predstavlja prvu vidljivu patohistološku promenu. Folikularna hiperkeratoza se ne može smatrati jedinim uzrokom akutnih zapaljenskih promena u folikulu (praćenih istovremenim nakupljanjem neutrofi la i razvojem intercelularnog edema u interfolikularnom epidermisu i papilarnom dermisu), zatim perifolikularnog umnožavanja kolagenih vlakana, nakupljanja mucina i mononuklearnih ćelija i u završnoj fazi destrukcijom dlačnog folikula: pretpostavlja se da za sada nepoznati etiološki faktor dovodi do oslobađanja citokina iz folikularnih keratinocita i da oslobođeni citokini izazivaju hiperkeratozu i infl amacijske promene koje potom slede. Opisani su brojni sindromi koje karakteriše prisustvo keratosis pilaris atrophicans. S obzirom da ovi sindromi imaju overlapping features and non-diagnostic histology as in our case, neki autori smatraju da oni predstavljaju različite faze u razvoju jednog istog procesa (tj. keratosis pilaris atrophicans), a da se na osnovu distribucije promena, jačine infl amacije i stepena nastale atrofi je, oni mogu svrstati u jednu od tri postojeće grupe koje svom izgledu karakterističan za lichen spinulosus može se lako odstraniti, pri čemu na njegovom mestu na papuli zaostaje prostor nalik na levak, dok kod KP zajedno sa keratinskim čepom biva odstranjena lezija u celini; 4. ichthyosis follicularis (IF) je prisutna na rođenju, karakteriše je neožiljna alopecija, u patohistološkom nalazu za razliku od keratosis follicularis spinulosa decalvans nema fi broze; 5. KAP sindrom (keratosis pilaris, alopecia, photophobia s. IF, alopecia i fotofobija) takođe je posledica mutacija u MBTPS2 genu na hromozomu Xp22, pa se može pretpostaviti da KAP sindrom i keratosis follicularis spinulosa decalvans predstavljaju overlap unutar spektra fenotipova jednog istog genetskog poremećaja ali je alopecija u KAP sindromu za razliku od keratosis follicularis spinulosa decalvans uvek neožiljna. Proces se u najvećem broju slučajeva zaustavlja tokom puberteta ali su posledice trajne. Lečenje je isključivo simptomatsko, specifi čna terapija ne postoji: retinoide (izotretinoin, acitretin) treba primenjivati samo u vreme aktivne faze oboljenja, što znači u ranom detinjstvu. Gubitak kose, odnosno dlaka je trajan, i svako lečenje u hroničnoj, stacionarnoj fazi, tj. posle puberteta, što je do sada bio najčešći slučaj, može samo ublažiti postojeće hiperkeratotične promene. Lečenje antibioticima treba sprovoditi samo u periodima akutnog pogoršanja, koje se kod manjeg broja obolelih manifestuje pojavom eritema i malog broja pustula na koži poglavine. Iz brisa promena može se izolovati Staphyloccocus aureus, a lečenje treba sprovesti prema antibiogramu. Lokalna primena keratolitika i kortikosteroida dovodi samo do delimičnog poboljšanja, a po prestanku lečenja njihov efekat se gubi. Tretinoin (0,1% krem jedanput dnevno), može izazvati na koži pojavu ili pogoršanje već postojećeg eritema, što se može izbeći istovremenom primenom kortikosteroidnih kremova (jedanput do dvaput dnevno), ili 0,025% retinoične kiseline na kapilicijum alternativno svake druge noći. Uklanjanje dlaka uz pomoć rubi lasera (engl. long-pulse non-Qswitched ruby laser) pokazalo se efi kasno u rekalcitrantnim progresivnim slučajevima KFSD. Atrofi čne promene mogu se lečiti dermobrazijom i/ili primenom kolagenih implantata što se danas smatra najuspešnijim metodom lečenja, a za izravnavanje površine kože mogu se primeniti ultrapulsni CO 2 ili YAG (yttrium aluminium garnet) laser. Značajno smanjenje eritema se može postići pomoću PDL lasera (engl. pulsed dye laser at 585 nm). Zaključak. Autori su prikazali overlap dve retke folikularne genokeratoze u slučaju mlade osobe muškog pola sa pozitivnom porodičnom anamnezom, kod koje je erythema ophryogenes, pored obrva, zahvatio i poglavinu u formi parietal, focal patchy cicatricial alopecia.
